ReviewBrain & spine2026
The association between bone density evaluated on CT or MRI versus the gold standard dual-energy X-ray absorptiometry (DEXA) in the lumbar spine and hip: a meta-analysis.
Review in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: CT-based Hounsfield units (HU) and MRI-based vertebral bone quality (VBQ)-scores are opportunistic markers of bone mineral density and potential alternatives for dual-energy X-ray absorptiometry (DEXA). Research question: What is the correlation between HU values and VBQ-scores in relation to DEXA, and what is the corresponding area-under-the-curve (AUC)-based diagnostic discrimination to detect osteopenia and osteoporosis? Material and methods: PubMed, Embase, Web of Science, Cochrane Library, and CINAHL were searched through August 2025 for studies reporting correlations between DEXA and CT and/or MRI or the AUC-based diagnostic discrimination of CT and/or MRI to detect osteopenia and osteoporosis. Random effects models were used to calculate pooled correlation coefficients and AUC values along with 95% confidence intervals. Results: Forty-three studies, including 8222 patients, were analyzed. HU demonstrated stronger correlations with DEXA T-scores than the VBQ-score (maximum correlation coefficient: 0.741 (95% CI: 0.578-0.847) vs. -0.476 (95% CI: -0.548 to -0.398) and greater AUC-based diagnostic discrimination for osteopenia and osteoporosis (maximum AUC: 0.875 (95% CI: 0.841-0.909) vs. 0.806 (95% CI: 0.684-0.929) across all vertebrae and DEXA sites. Correlation and AUC-based diagnostic discrimination of HU were consistent across vertebrae, with slightly better results at L2 and the mean of L1-L4. VBQ-score correlations were highest at L1 and gradually decreased from L1 to L4. Discussion and conclusion: When CT is available, HU appears to be the better-supported opportunistic marker for low BMD than VBQ. All vertebrae demonstrated comparable correlation and AUC-based diagnostic discrimination, with L2 HU and the mean of L1-L4 HU showing slightly superior results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.